U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H7NO
Molecular Weight 61.0831
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-Aminoethanol

SMILES

NCCO

InChI

InChIKey=HZAXFHJVJLSVMW-UHFFFAOYSA-N
InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2

HIDE SMILES / InChI

Molecular Formula C2H7NO
Molecular Weight 61.0831
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Monoethanolamine is both a primary amine and a primary alcohol. It is an olamine derivative. Monoethanolamine occurs in every cell in the human body as the head group of Phosphatidylethanolamine. Monoethanolamine is a component of glycosylphosphatidylinositol-anchored proteins, which are essential for viability. Other sources of monoethanolamine or phosphoethanolamine in the human body are the degradation of sphingosine phosphate by sphingosine phosphate lyase and the degradation of the endocannabinoid anandamide by the fatty acid amine hydrolase. Monoethanolamine stimulates the rapid growth of mammalian cells in culture. Monoethanolamine has a cardioprotective role against ischemia/reperfusion injury via activation of the transcription factor STAT-3. Monoethanolamine is a chemical intermediate in the manufacture of cosmetics, surface-active agents, emulsifiers, pharmaceuticals, and plasticizing agents.

Originator

Sources: DOI: 10.1002/cber.189703001178

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Involvement of delta-aminolaevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum.
2002-10-15
Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes.
2002-10
Evaluation and optimization of DNA delivery into gliosarcoma 9L cells by a cholesterol-based cationic liposome.
2002-08-31
Phosphatidyl ethanolamine is essential for targeting the arginine transporter Can1p to the plasma membrane of yeast.
2002-08-19
Amiodarone-induced phospholipidosis: an in vivo [14C]-acetate uptake study in rat.
2002-08
Computational exploration of rearrangements related to the vitamin B12-dependent ethanolamine ammonia lyase catalyzed transformation.
2002-07-31
Dietary n-3 and n-6 fatty acids alter avian metabolism: molecular-species composition of breast-muscle phospholipids.
2002-07
Algicidal effectiveness of Clearigate, Cutrine-Plus, and copper sulfate and margins of safety associated with their use.
2002-07
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
2002-06-08
LC-MS/MS identification of in vitro metabolites of a new H+/K+ ATPase inhibitor, KR-60436 produced by rat and human liver microsomes.
2002-06-01
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
2002-06
Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
2002-05-23
Structure-activity relationships of lysophosphatidic acid analogs.
2002-05-23
Expression and characterization of the active molecular forms of choline/ethanolamine kinase-alpha and -beta in mouse tissues, including carbon tetrachloride-induced liver.
2002-05-01
Endometriosis in reproductive immunology.
2002-05
Phospholipid biosynthesis in the oyster protozoan parasite, Perkinsus marinus.
2002-05
Characterization of the hom-thrC-thrB cluster in aminoethoxyvinylglycine-producing Streptomyces sp. NRRL 5331.
2002-05
Thermal study of simple amino-alcohol solutions.
2002-04
Detection of ligands for selectins in the oligosaccharide fraction of human milk.
2002-04
Glycosylphosphatidylinositol (GPI)-anchored proteins.
2002-04
Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the beta(2)-adrenergic receptor.
2002-04
Endoscopic management and long-term follow-up of Dieulafoy's lesions in the upper GI tract.
2002-04
Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor.
2002-03-28
Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation.
2002-03-15
Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications for parasite virulence.
2002-03-15
Behavior and characteristics of amine derivatives obtained with o-phthaldialdehyde/3-mercaptopropionic acid and with o-phthaldialdehyde/N-acetyl-L-cysteine reagents.
2002-03-08
Comparative study of the effects of short- and long-term ethanol treatment and alcohol withdrawal on phospholipid biosynthesis in rat hepatocytes.
2002-03
Saccharomonospora halophila sp. nov., a novel halophilic actinomycete isolated from marsh soil in Kuwait.
2002-03
Kinetic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis using (13)C NMR spectroscopy.
2002-02-28
Regulation of phosphatidylcholine and phosphatidylethanolamine synthesis in rat hepatocytes by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
2002-02-15
New structures of the O-specific polysaccharides of bacteria of the genus Proteus. 1. Phosphate-containing polysaccharides.
2002-02
(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity.
2002-02
Cytoskeletal inhibitors, anti-adhesion molecule antibodies, and lectins inhibit hepatocyte spheroid formation.
2002-02
Rapid synthesis and turnover of brain microsomal ether phospholipids in the adult rat.
2002-01
Poly(amide ester)s from 2,6-pyridinedicarboxylic acid and ethanolamine derivatives: identification of macrocycles by matrix-assisted laser desorption/ionization mass spectrometry.
2002
[Structural and metabolic status and functional properties of erythrocytes in schizophrenic patients].
2002
Ethanolamine is a co-mitogenic factor for proliferation of primary hepatocytes.
2002
Beta 3 agonists. Part 1: evolution from inception to BMS-194449.
2001-12-03
Liquid ionization mass spectrometry of some triorganotin carboxylates.
2001-12
Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM).
2001-12
Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative.
2001-11-19
Reductive demercuration in deprotection of trityl thioethers, trityl amines, and trityl ethers.
2001-11-16
Luminol chemiluminescence in unbuffered solutions with a cobalt(II)-ethanolamine complex immobilized on resin as catalyst and its application to analysis.
2001-11-01
Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria.
2001-11
Nature of glycosylphosphatidylinositols produced by mouse embryonic stem cells.
2001-11
Tissue-specific and developmental effects of the easily shocked mutation on ethanolamine kinase activity and phospholipid composition in Drosophila melanogaster.
2001-10
Maternal-fetal n-6 and n-3 polyunsaturated fatty acids gradient in plasma and red cell phospholipids.
2001-09
Structure-activity relationship studies of (+/-)-terbutaline and (+/-)-fenoterol on beta3-adrenoceptors in the guinea pig gastric fundus.
2001-08
Binding specificity of Bacillus thuringiensis Cry1Aa for purified, native Bombyx mori aminopeptidase N and cadherin-like receptors.
2001
The linkage between beta1 integrin and the actin cytoskeleton is differentially regulated by tyrosine and serine/threonine phosphorylation of beta1 integrin in normal and cancerous human breast cells.
2001
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Ethanolamine is a product of metabolism of sphingosine-1-phosphate (of S1P)
Rat: single injection 5 mg/kg of S1P
Route of Administration: Intravenous
1 uM of Monoethanolamine is required to activate virulence gene expression in Escherichia coli O157:H7 (EHEC), and this concentration is far below the concentration required for ethanolamine to be used as a nitrogen source.
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:19:43 GMT 2025
Edited
by admin
on Wed Apr 02 09:19:43 GMT 2025
Record UNII
5KV86114PT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ethanolamine
HSDB   INCI   MI   WHO-DD  
INCI  
Preferred Name English
2-Aminoethanol
Systematic Name English
Monoethanolamine [II]
Common Name English
IFOSFAMIDE IMPURITY D [EP IMPURITY]
Common Name English
Monoethanolamine
II   USP-RS  
Systematic Name English
Monoethanolamine [USP-RS]
Common Name English
Olamine [INN]
Common Name English
Ethanolamine [EP MONOGRAPH]
Common Name English
Ethanolamine [WHO-DD]
Common Name English
Ethanolamine [HSDB]
Common Name English
Ethanolamine [MI]
Common Name English
Olamine
INN  
INN  
Official Name English
TROLAMINE IMPURITY A [EP IMPURITY]
Common Name English
Classification Tree Code System Code
LOINC 34300-4
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 28605-4
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 26608-0
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 56678-6
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 2264-0
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 13740-6
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
NDF-RT N0000175814
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
NDF-RT N0000009905
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 15137-3
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 26593-4
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 15142-3
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 25910-1
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
EPA PESTICIDE CODE 11601
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
NDF-RT N0000020024
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 49633-1
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 32239-6
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 25098-5
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
NCI_THESAURUS C29578
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 13613-5
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 6881-7
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 2263-2
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 25911-9
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
FDA ORPHAN DRUG 416713
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 25405-2
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
LOINC 26803-7
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
Code System Code Type Description
CHEBI
23981
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID6022000
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
MESH
D019856
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
PUBCHEM
700
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
RXCUI
24457
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY RxNorm
CHEBI
16000
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
CHEBI
57603
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
NCI_THESAURUS
C61756
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
SMS_ID
100000092555
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
EVMPD
SUB01990MIG
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
HSDB
531
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
DAILYMED
5KV86114PT
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
CAS
141-43-5
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
WIKIPEDIA
ETHANOLAMINE
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-483-3
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL104943
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
FDA UNII
5KV86114PT
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
DRUG BANK
DB03994
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
MERCK INDEX
m5052
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY Merck Index
RS_ITEM_NUM
1445925
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
INN
497
Created by admin on Wed Apr 02 09:19:43 GMT 2025 , Edited by admin on Wed Apr 02 09:19:43 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
PARENT -> CONSTITUENT ALWAYS PRESENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (GC)
EP
Related Record Type Details
ACTIVE MOIETY